Delivery Order SPE2DB25D3006-SPE2DB25FXKLN
Award Date 9/16/25
Potential Completion Date 9/17/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,601.50 to AmerisourceBergen Drug Corp for Vyvanse 30 mg capsules (100 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order represents a non-competitive set-aside transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication commonly used to treat...
- The Defense Logistics Agency awarded a delivery order valued at $2,189.62 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Vyvanse 30 mg capsules (100 count). This non-set-aside, firm fixed price delivery order is scheduled for ultimate completion on August 6, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and binge eating disorder,...
- The Defense Logistics Agency awarded a delivery order valued at $1,407.17 to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules (100-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication commonly used in military and veteran...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,916.37 for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on November 18, 2025, with an ultimate completion date of November 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $4,991.73 to AmerisourceBergen Drug Corp for the supply of Vyvanse 50 mg capsules (100 count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania facility. Vyvanse is a prescription stimulant medication commonly used to treat attention deficit...
- The Defense Logistics Agency awarded a delivery order valued at $1,775.04 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vyvanse is a prescription medication commonly used to treat attention-deficit/hyperactivity disorder and binge...
- The Defense Logistics Agency awarded a delivery order valued at $6,321.44 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription medication used in the treatment of attention deficit hyperactivity...
- The Defense Logistics Agency awarded a delivery order valued at $1,372.32 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 60 mg on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work is to...
- The Defense Logistics Agency awarded a $1,754.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for Vyvanse 30 mg capsules (100 count) on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,676.98 to AmerisourceBergen Drug Corp for Vyvanse 50 mg capsules (100 count) on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside contract represents a firm fixed-price delivery order to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription medication commonly used in military and veteran healthcare systems for the treatment of...